Barros Veridiana Ester, dos Santos-Junior Nilton Nascimento, Amarilla Alberto Anastacio, Soares Adriana Moreira, Lourencini Rafael, Trabuco Amanda Cristina, Aquino Victor Hugo
Laboratory of Virology, Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Av do Café, s/n, CEP: 14040-903, Ribeirao Preto, Sao Paulo, Brazil.
BMC Microbiol. 2015 Sep 29;15:189. doi: 10.1186/s12866-015-0520-7.
Several experimental animal models have been used to study the pathogenesis of dengue disease; however, most of the studies used laboratory-adapted viruses, which lack the virulence of viruses circulating in humans. The aim of this study was to analyze the ability of clinical Dengue virus (DENV) isolates (D2/BR/RP/RMB/09 and D3/BR/SL3/02) to infect immunocompetent C57BL/6 mice.
Two strategies of intraperitoneal infection, which were based on the concept of the antibody dependent enhancement phenomenon, were used. In one strategy, the animals were inoculated with macrophages infected in vitro with dengue viruses, which were incubated with enhancing antibodies, and in the other strategy, the animals were inoculated with a complex of enhancing antibodies and dengue viruses.
The D3/BR/SL3/08 isolate showed a higher ability of infection (virus RNA was more frequently detected in the serum and in several organs) in the experimental model compared to both the D2/BR/RP/RMB/2009 isolate and a laboratory adapted DENV-1 strain (Mochizuki strain), regardless of the infection strategy used. The main features of the D3/BR/SL3/08 isolate were its neuroinvasiveness and the induction of an extended period of viremia. Enhancing antibodies did not influence on the infection of animals when macrophages were used, but the level of viremia was increased when they were used as a complex with a D3/BR/SL3/02 isolate.
We showed that DENV isolates could infect immunocompetent C57BL/6 mice, which have has been previously used to study some aspect of dengue disease when infected with laboratory adapted strains. DENV genome was detected in the same organs found in humans when autopsy and biopsy samples were analyzed, showing that C57BL/6 mice reproduce some aspects of the DENV tropism observed in humans. The main difference observed between the D3/BR/SL3/02 and D2/BR/RP/RMB/2009 clinical isolates was the neuroinvasive ability of the first one. Neuroinvasiveness has been described in some DENV infected cases and is common for other members of the Flavivirus genus.
These results suggest that C57BL/6 mice can be used as an experimental model to evaluate virulence differences among DENV clinical isolates.
已有多种实验动物模型用于研究登革热疾病的发病机制;然而,大多数研究使用的是实验室适应病毒,这些病毒缺乏在人类中传播的病毒的毒力。本研究的目的是分析临床登革病毒(DENV)分离株(D2/BR/RP/RMB/09和D3/BR/SL3/02)感染免疫功能正常的C57BL/6小鼠的能力。
基于抗体依赖增强现象的概念,采用了两种腹腔感染策略。在一种策略中,给动物接种体外感染登革病毒的巨噬细胞,这些巨噬细胞与增强抗体一起孵育;在另一种策略中,给动物接种增强抗体和登革病毒的复合物。
与D2/BR/RP/RMB/2009分离株和实验室适应的DENV-1株(望月株)相比,无论采用何种感染策略,D3/BR/SL3/08分离株在实验模型中均表现出更高的感染能力(在血清和多个器官中更频繁地检测到病毒RNA)。D3/BR/SL3/08分离株的主要特征是其神经侵袭性和诱导长时间的病毒血症。当使用巨噬细胞时,增强抗体对动物感染没有影响,但当它们与D3/BR/SL3/02分离株作为复合物使用时,病毒血症水平会升高。
我们表明,DENV分离株可以感染免疫功能正常的C57BL/6小鼠,此前该小鼠在感染实验室适应株时已被用于研究登革热疾病的某些方面。在分析尸检和活检样本时,在人类发现的相同器官中检测到了DENV基因组,表明C57BL/6小鼠再现了人类中观察到的DENV嗜性的某些方面。在D3/BR/SL3/02和D2/BR/RP/RMB/2009临床分离株之间观察到的主要差异是前者的神经侵袭能力。神经侵袭性在一些DENV感染病例中已有描述,并且在黄病毒属的其他成员中很常见。
这些结果表明,C57BL/6小鼠可作为评估DENV临床分离株毒力差异的实验模型。